PermitFlow vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Construction permitting automation across 10,000+ US jurisdictions for contractors and developers; $37M raised with Kleiner Perkins Series A, 5,000+ housing units permitted, 20x ARR growth in 2023.
About
PermitFlow is a San Francisco-based construction permitting automation company that streamlines the entire permit lifecycle from research through final approval — providing contractors, developers, and homebuilders with software that handles jurisdiction research, application preparation, document management, fee calculation, and status tracking across the thousands of local government permit offices in the United States. Founded in 2021 and a Y Combinator Winter 2022 graduate, PermitFlow raised $37 million total including a $31 million Series A led by Kleiner Perkins in February 2024, having facilitated permits for 5,000+ housing units and achieved 20x+ year-over-year ARR growth in 2023.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.